Sign inJoin waitlistJoin the waitlist

Robin Norris

Director · Cincinnati Children's Hospital Medical Center

Credentials: · · · · · ·

History

University of Cincinnati Medical Center Inc.
Present
Cincinnati Children's Hospital Medical Center
Present

Pediatric Hematology Oncology
Children's Hospital of Philadelphia
2005–2008
Pediatrics
University of California-San Francisco
2001–2002
Perelman School of Medicine at the University of Pennsylvania
Perelman School of Medicine at the University of Pennsylvania
1997–2001
Human Biology, Stanford University, Stanford, CA, 1997
1993–1997

Research

Venetoclax and Navitoclax in Combination with Chemotherapy in Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma
Cancer Discovery · 2021 · 256 citations
mTOR inhibitors are synergistic with methotrexate: an effective combination to treat acute lymphoblastic leukemia
Blood · 2008 · 91 citations
Phase 1 trial of temsirolimus in combination with irinotecan and temozolomide in children, adolescents and young adults with relapsed or refractory solid tumors: a Children's…
Pediatric Blood & Cancer · 2014 · 83 citations

Peter Adamson
8 papers
Ahna Pai
7 papers
John Perentesis
5 papers
Tyler Ketterl
5 papers
Benjamin Mizukawa
4 papers
Christine Phillips
4 papers
Erin Breese
4 papers
Maureen O'Brien
4 papers
Brenda Weigel
3 papers
Elizabeth Fox
3 papers
Jeremy Rubinstein
3 papers · 1 as a fellow
Karen Burns
3 papers

Clinical trials

MORAb-004 in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma
Principal investigator · Completed · Phase 1
Morphotek
2013–2015
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Site PI · Recruiting · Phase 3
National Cancer Institute (NCI)
2023–2031
A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
Site PI · Recruiting · Phase 2
Children's Oncology Group
2020–2027
Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects
Site PI · Recruiting
Alliance for Clinical Trials in Oncology
2020–2026